Clinical Trial Update: Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma [NA]

View source ↗

Summary

A completed clinical trial evaluated the molecular effects of short-term Celecoxib treatment in head and neck squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: SQUAMOUS CELL CARCINOMA | NA | Status: COMPLETED